• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎患者的粪便微生物组存在一致改变,与相关结肠炎无关。

Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.

机构信息

Kiel, Germany.

Hamburg, Germany.

出版信息

Aliment Pharmacol Ther. 2019 Sep;50(5):580-589. doi: 10.1111/apt.15375. Epub 2019 Jun 28.

DOI:10.1111/apt.15375
PMID:31250469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6899739/
Abstract

BACKGROUND

Single-centre studies reported alterations of faecal microbiota in patients with primary sclerosing cholangitis (PSC). As regional factors may affect microbial communities, it is unclear if a microbial signature of PSC exists across different geographical regions.

AIM

To identify a robust microbial signature of PSC independent of geography and environmental influences.

METHODS

We included 388 individuals (median age, 47 years; range, 15-78) from Germany and Norway in the study, 137 patients with PSC (n = 75 with colitis), 118 with ulcerative colitis (UC) and 133 healthy controls. Faecal microbiomes were analysed by 16S rRNA gene sequencing (V1-V2). Differences in relative abundances of single taxa were subjected to a meta-analysis.

RESULTS

In both cohorts, microbiota composition (beta-diversity) differed between PSC patients and controls (P < 0.001). Random forests classification discriminated PSC patients from controls in both geographical cohorts with an average area under the curve of 0.88. Compared to healthy controls, many new cohort-spanning alterations were identified in PSC, such as an increase of Proteobacteria and the bile-tolerant genus Parabacteroides, which were detected independent from geographical region. Associated colitis only had minor effects on microbiota composition, suggesting that PSC itself drives the faecal microbiota changes observed.

CONCLUSION

Compared to healthy controls, numerous microbiota alterations are reproducible in PSC patients across geographical regions, clearly pointing towards a microbiota composition that is shaped by the disease itself and not by environmental factors. These reproducibly altered microbial populations might provide future insights into the pathophysiology of PSC.

摘要

背景

单中心研究报道原发性硬化性胆管炎(PSC)患者粪便微生物群发生改变。由于区域因素可能会影响微生物群落,因此尚不清楚 PSC 是否存在跨越不同地理区域的微生物特征。

目的

确定 PSC 的微生物特征,不受地理和环境影响。

方法

我们纳入了来自德国和挪威的 388 名个体(中位年龄,47 岁;范围,15-78 岁),包括 137 名 PSC 患者(75 名结肠炎患者)、118 名溃疡性结肠炎患者和 133 名健康对照者。通过 16S rRNA 基因测序(V1-V2)分析粪便微生物组。对单一种类的相对丰度差异进行荟萃分析。

结果

在两个队列中,PSC 患者与对照组的微生物群落组成(β多样性)存在差异(P < 0.001)。随机森林分类可在两个地理队列中区分 PSC 患者与对照组,平均曲线下面积为 0.88。与健康对照组相比,在 PSC 中鉴定出许多新的跨队列改变,例如厚壁菌门和耐胆菌属 Parabacteroides 的增加,这些改变独立于地理区域。相关结肠炎仅对微生物群落组成产生较小影响,表明观察到的粪便微生物变化是由 PSC 本身驱动的。

结论

与健康对照组相比,在 PSC 患者中,跨越地理区域的微生物群改变数量众多,这清楚地表明了由疾病本身而不是环境因素塑造的微生物组成。这些可重复改变的微生物群可能为 PSC 的病理生理学提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7527/6899739/8a4950f593ba/APT-50-580-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7527/6899739/7458ea5e8441/APT-50-580-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7527/6899739/f7fee35e0b09/APT-50-580-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7527/6899739/9252f869da3b/APT-50-580-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7527/6899739/8a4950f593ba/APT-50-580-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7527/6899739/7458ea5e8441/APT-50-580-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7527/6899739/f7fee35e0b09/APT-50-580-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7527/6899739/9252f869da3b/APT-50-580-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7527/6899739/8a4950f593ba/APT-50-580-g004.jpg

相似文献

1
Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.原发性硬化性胆管炎患者的粪便微生物组存在一致改变,与相关结肠炎无关。
Aliment Pharmacol Ther. 2019 Sep;50(5):580-589. doi: 10.1111/apt.15375. Epub 2019 Jun 28.
2
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.原发性硬化性胆管炎患者的肠道微生物谱与无胆道疾病的溃疡性结肠炎患者和健康对照者不同。
Gut. 2017 Apr;66(4):611-619. doi: 10.1136/gutjnl-2015-310500. Epub 2016 Feb 17.
3
Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.伴有和不伴有原发性硬化性胆管炎的溃疡性结肠炎患者肠道微生物群的特征分析
J Crohns Colitis. 2016 Mar;10(3):330-7. doi: 10.1093/ecco-jcc/jjv204. Epub 2015 Nov 2.
4
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.原发性硬化性胆管炎和溃疡性结肠炎患者不同的肠道微生物群特征。
World J Gastroenterol. 2017 Jul 7;23(25):4548-4558. doi: 10.3748/wjg.v23.i25.4548.
5
Altered Bile Acid and Pouch Microbiota Composition in Patients With Chronic Pouchitis.慢性袋炎患者胆汁酸和袋内微生物群落组成的改变。
Inflamm Bowel Dis. 2024 Jul 3;30(7):1062-1070. doi: 10.1093/ibd/izad288.
6
Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.意大利儿科原发性硬化性胆管炎和溃疡性结肠炎患者的肠道微生物群和真菌群特征。
Inflamm Bowel Dis. 2024 Apr 3;30(4):529-537. doi: 10.1093/ibd/izad203.
7
A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.原发性硬化性胆管炎-炎症性肠病的结肠基因表达、肠道微生物群和免疫浸润的综合分析:疾病与胆汁酸途径的关联。
J Crohns Colitis. 2020 Jul 30;14(7):935-947. doi: 10.1093/ecco-jcc/jjaa021.
8
Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis.原发性硬化性胆管炎合并溃疡性结肠炎患儿和青少年的肠道微生物组。
Front Immunol. 2021 Feb 5;11:598152. doi: 10.3389/fimmu.2020.598152. eCollection 2020.
9
Alterations of the bile microbiome in primary sclerosing cholangitis.原发性硬化性胆管炎胆汁微生物组的改变。
Gut. 2020 Apr;69(4):665-672. doi: 10.1136/gutjnl-2019-318416. Epub 2019 Jun 26.
10
The features of mucosa-associated microbiota in primary sclerosing cholangitis.原发性硬化性胆管炎中黏膜相关微生物群的特征。
Aliment Pharmacol Ther. 2016 Apr;43(7):790-801. doi: 10.1111/apt.13552. Epub 2016 Feb 9.

引用本文的文献

1
Exploring causal links between autoimmune liver diseases, chronic hepatitis C, and thyroid disorders: Evidence from NHANES and GWAS studies.探索自身免疫性肝病、慢性丙型肝炎和甲状腺疾病之间的因果联系:来自美国国家健康与营养检查调查(NHANES)和全基因组关联研究(GWAS)的证据。
Medicine (Baltimore). 2025 Aug 29;104(35):e44112. doi: 10.1097/MD.0000000000044112.
2
Impact of Gut Microbiome on Gut Permeability in Liver and Gut Diseases.肠道微生物群对肝脏和肠道疾病中肠道通透性的影响。
Microorganisms. 2025 May 23;13(6):1188. doi: 10.3390/microorganisms13061188.
3
Oral microbiota and biliary tract cancers: unveiling hidden mechanistic links.

本文引用的文献

1
Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.原发性硬化性胆管炎中肠道共生菌导致肠道屏障功能障碍和肝脏辅助性 T 细胞 17 免疫应答。
Nat Microbiol. 2019 Mar;4(3):492-503. doi: 10.1038/s41564-018-0333-1. Epub 2019 Jan 14.
2
Primary sclerosing cholangitis - a comprehensive review.原发性硬化性胆管炎——全面综述。
J Hepatol. 2017 Dec;67(6):1298-1323. doi: 10.1016/j.jhep.2017.07.022. Epub 2017 Aug 10.
3
Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
口腔微生物群与胆道癌:揭示隐藏的机制联系
Front Oncol. 2025 Jun 11;15:1585923. doi: 10.3389/fonc.2025.1585923. eCollection 2025.
4
Highland Barley Improves DSS-Induced Ulcerative Colitis in C57BL/6J Mice.青稞改善DSS诱导的C57BL/6J小鼠溃疡性结肠炎。
Food Sci Nutr. 2025 May 5;13(5):e70132. doi: 10.1002/fsn3.70132. eCollection 2025 May.
5
The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review.口服万古霉素对原发性硬化性胆管炎患者炎症性肠病的疗效:一项系统评价
Inflamm Bowel Dis. 2025 Jul 7;31(7):2027-2035. doi: 10.1093/ibd/izae257.
6
Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications.胆汁纤维化是肝胆疾病中一个重要但被忽视的病理特征:从分子机制到临床意义。
Med Rev (2021). 2024 Jul 1;4(4):326-365. doi: 10.1515/mr-2024-0029. eCollection 2024 Aug.
7
Early Deregulation of Cholangiocyte NR0B2 During Primary Sclerosing Cholangitis.原发性硬化性胆管炎期间胆管细胞NR0B2的早期去调控
Gastro Hep Adv. 2022 Aug 13;2(1):49-62. doi: 10.1016/j.gastha.2022.07.023. eCollection 2023.
8
A Review on Biomarkers for the Evaluation of Autoimmune Cholestatic Liver Diseases and Their Overlap Syndromes.自身免疫性胆汁淤积性肝病及其重叠综合征评估的生物标志物综述
Front Mol Med. 2022 Jul 8;2:914505. doi: 10.3389/fmmed.2022.914505. eCollection 2022.
9
Inflammatory bowel disease associated with primary sclerosing cholangitis is associated with an altered gut microbiome and bile acid profile.与原发性硬化性胆管炎相关的炎症性肠病与肠道微生物群和胆汁酸谱的改变有关。
J Crohns Colitis. 2024 Jul 9;18(12):1957-66. doi: 10.1093/ecco-jcc/jjae096.
10
Protective function of sclerosing cholangitis on IBD.硬化性胆管炎对炎症性肠病的保护作用。
Gut. 2024 Jul 11;73(8):1292-1301. doi: 10.1136/gutjnl-2023-330856.
原发性硬化性胆管炎和溃疡性结肠炎患者不同的肠道微生物群特征。
World J Gastroenterol. 2017 Jul 7;23(25):4548-4558. doi: 10.3748/wjg.v23.i25.4548.
4
Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis.冷诱导的胆固醇向胆汁酸的转化在小鼠中塑造了肠道微生物组,并促进了适应性产热。
Nat Med. 2017 Jul;23(7):839-849. doi: 10.1038/nm.4357. Epub 2017 Jun 12.
5
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.患者年龄、性别及炎症性肠病表型与原发性硬化性胆管炎病程相关。
Gastroenterology. 2017 Jun;152(8):1975-1984.e8. doi: 10.1053/j.gastro.2017.02.038. Epub 2017 Mar 6.
6
Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.原发性胆汁性胆管炎患者的肠道微生物群特征发生改变,熊去氧胆酸治疗后部分恢复。
Gut. 2018 Mar;67(3):534-541. doi: 10.1136/gutjnl-2016-313332. Epub 2017 Feb 17.
7
Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota.全基因组关联分析确定了维生素D受体及其他影响肠道微生物群的宿主因素的变异。
Nat Genet. 2016 Nov;48(11):1396-1406. doi: 10.1038/ng.3695. Epub 2016 Oct 10.
8
Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.肠道菌群失调、炎症与治疗反应:一项针对新诊断的炎症性肠病儿科患者的纵向研究。
Genome Med. 2016 Jul 13;8(1):75. doi: 10.1186/s13073-016-0331-y.
9
Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.磁共振胆管成像检测长期炎症性肠病患者硬化性胆管炎的患病率。
Gastroenterology. 2016 Oct;151(4):660-669.e4. doi: 10.1053/j.gastro.2016.06.021. Epub 2016 Jun 21.
10
Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.粪便微生物群谱作为原发性硬化性胆管炎的诊断生物标志物
Gut. 2017 Apr;66(4):753-754. doi: 10.1136/gutjnl-2016-312180. Epub 2016 May 23.